Nautilus Biotechnology IncNASDAQ:NAUT
- LAST PRICE2.8600
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots2.5400/ 8
- Ask / Lots3.6900/ 1
- Open / Previous Close0.0000 / 2.8600
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NAUT |
|---|---|---|
| 09:32 ET | 1278 | 2.8 |
| 09:45 ET | 1350 | 2.7918 |
| 09:57 ET | 1545 | 2.865 |
| 10:01 ET | 497 | 2.84 |
| 10:06 ET | 1300 | 2.87 |
| 10:14 ET | 100 | 2.84 |
| 10:15 ET | 4300 | 2.84 |
| 10:30 ET | 504 | 2.8491 |
| 10:32 ET | 100 | 2.85 |
| 10:33 ET | 713 | 2.83 |
| 10:39 ET | 600 | 2.85 |
| 10:42 ET | 100 | 2.84 |
| 10:51 ET | 483 | 2.87 |
| 10:53 ET | 500 | 2.87 |
| 10:57 ET | 123 | 2.87 |
| 11:02 ET | 100 | 2.8607 |
| 11:04 ET | 2420 | 2.85 |
| 11:06 ET | 100 | 2.84 |
| 11:08 ET | 100 | 2.85 |
| 11:15 ET | 4725 | 2.8724 |
| 11:22 ET | 300 | 2.89 |
| 11:26 ET | 700 | 2.89 |
| 11:27 ET | 200 | 2.89 |
| 11:29 ET | 200 | 2.89 |
| 11:31 ET | 1531 | 2.88 |
| 11:33 ET | 200 | 2.875 |
| 11:38 ET | 200 | 2.88 |
| 11:42 ET | 961 | 2.87 |
| 11:54 ET | 100 | 2.86 |
| 12:03 ET | 1000 | 2.8692 |
| 12:05 ET | 100 | 2.865 |
| 12:12 ET | 200 | 2.88 |
| 12:14 ET | 200 | 2.88 |
| 12:16 ET | 100 | 2.89 |
| 12:20 ET | 200 | 2.89 |
| 12:21 ET | 100 | 2.89 |
| 12:23 ET | 1976 | 2.8997 |
| 12:25 ET | 200 | 2.9 |
| 12:30 ET | 319 | 2.9 |
| 12:32 ET | 200 | 2.91 |
| 12:34 ET | 200 | 2.91 |
| 12:36 ET | 770 | 2.91 |
| 12:38 ET | 3477 | 2.91 |
| 12:39 ET | 367 | 2.91 |
| 12:43 ET | 100 | 2.91 |
| 12:52 ET | 100 | 2.91 |
| 12:54 ET | 1494 | 2.9 |
| 01:12 ET | 600 | 2.8993 |
| 01:17 ET | 506 | 2.89 |
| 01:21 ET | 300 | 2.8831 |
| 01:24 ET | 1537 | 2.9 |
| 01:42 ET | 1019 | 2.89 |
| 01:53 ET | 100 | 2.89 |
| 02:02 ET | 1646 | 2.91 |
| 02:04 ET | 100 | 2.91 |
| 02:08 ET | 200 | 2.915 |
| 02:11 ET | 987 | 2.9 |
| 02:18 ET | 100 | 2.8999 |
| 02:27 ET | 430 | 2.9 |
| 02:29 ET | 200 | 2.91 |
| 02:45 ET | 900 | 2.925 |
| 02:54 ET | 100 | 2.922 |
| 02:56 ET | 2153 | 2.93 |
| 02:58 ET | 1119 | 2.91 |
| 03:02 ET | 500 | 2.89 |
| 03:05 ET | 100 | 2.89 |
| 03:09 ET | 2100 | 2.9 |
| 03:12 ET | 1400 | 2.88 |
| 03:14 ET | 200 | 2.875 |
| 03:16 ET | 100 | 2.875 |
| 03:18 ET | 400 | 2.87 |
| 03:20 ET | 733 | 2.8761 |
| 03:21 ET | 3265 | 2.9 |
| 03:25 ET | 1100 | 2.89 |
| 03:30 ET | 418 | 2.88 |
| 03:34 ET | 100 | 2.89 |
| 03:36 ET | 314 | 2.8707 |
| 03:38 ET | 300 | 2.88 |
| 03:39 ET | 100 | 2.89 |
| 03:41 ET | 138 | 2.88 |
| 03:45 ET | 100 | 2.88 |
| 03:48 ET | 410 | 2.875 |
| 03:50 ET | 1837 | 2.87 |
| 03:52 ET | 630 | 2.87 |
| 03:54 ET | 400 | 2.86 |
| 03:56 ET | 800 | 2.87 |
| 03:57 ET | 500 | 2.86 |
| 03:59 ET | 13907 | 2.86 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nautilus Biotechnology Inc | 356.0M | -6.2x | --- |
Humacyte Inc | 359.5M | -13.8x | --- |
Forma Therapeutics Holdings Inc | 365.2M | -2.0x | --- |
Entrada Therapeutics Inc | 375.1M | 0.0x | --- |
Aerovate Therapeutics Inc | 376.2M | -11.7x | --- |
Biomea Fusion Inc | 333.7M | -6.2x | --- |
Company Information
Nautilus Biotechnology, Inc. is a development stage life sciences company. The Company is engaged in creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company focused on transforming the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its platform end-to-end solution comprised of the proteome analysis system, consumables, and software. The Company is developing a prototype of a single-molecule instrument, Proteomic Analysis System. The Company’s Proteomic Analysis Platform leverages a nanofabricated, single-molecule protein array, multi-cycle imaging, and machine learning analysis to identify and measure the proteome with sensitivity and scale.
Contact Information
- Headquarters
- 2701 Eastlake Ave East, Suite 202SEATTLE, WA, United States 98102
- Phone
- 206-333-2001
- Fax
- 302-655-5049
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $356.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 124.5M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-0.46 |
Book Value | $2.92 |
P/E Ratio | -6.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
